FTC Preparing Suit Against Drug Middlemen Over Insulin Rebates

The US Federal Trade Commission is preparing a lawsuit against the three largest drug middlemen over their use of rebates for insulin and other drugs, according to a person familiar with the probe.

The agency has been investigating whether the rebate practices of insulin manufacturers and the three largest pharmacy benefit managers – units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. – violate federal law, said the person, who asked not to be named discussing an ongoing probe. The insulin market is dominated by three manufacturers: Eli Lilly & Co., Sanofi SA, and Novo ...